Sanofi has entered into an agreement to acquire Vigil Neuroscience Inc., a publicly traded clinical-stage biotechnology ...

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

The new bioconjugation site completes the CDMO’s capabilities across payload, linker, and Mab, with onboarding set to start ...

The nasal route offers a number of benefits over some of the traditional routes of administration for biologics.

There have been a growing number of drug products approved that look to target the brain following intranasal delivery.

Traditionally, spray drying has been utilized as a useful technology for enhancing the delivery of small molecules via the ...

Interest in developing nasal dosage forms has increased significantly in the last two years, driven by a number of recent ...

The need for drying technologies to stabilize drug products containing biologics Drug products containing active biological ...

The U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Celltrion’s YUFLYMA.